NCT04108208 2026-04-13
A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)
Janssen Research & Development, LLC
Phase 4 Active not recruiting
Clinical Trials
24 trialsNCT01673984 2025-05-23
GREAT
Ipsen
Phase 4 Terminated
NCT04134208 2025-01-16
An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT02918968 2024-12-09
Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer
Astellas Pharma Inc
Phase 4 Completed
NCT03035032 2024-11-26
A Study of ELIGARDĀ® in Hormone-dependent Prostate Cancer Patients
Astellas Pharma Inc
Phase 4 Completed
NCT01794793 2024-10-01
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
RECORDATI GROUP
Phase 4 Completed
NCT05803096 2024-01-30
Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain
Beth Israel Deaconess Medical Center
Phase 4 Completed
NCT03824808 2023-10-25
Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery
University of Missouri-Columbia
Phase 4 Terminated
NCT01995513 2023-09-18
PLATO
Pfizer
Phase 4 Completed
NCT03796195 2023-01-25
(SGB) in Men Treated for Prostate Cancer Improve Hot Flashes
Northwestern University
Phase 4 Terminated
NCT01753297 2020-12-09
PRIORITI
Ipsen
Phase 4 Completed
NCT03006562 2020-08-05
PREVENTER
Johns Hopkins University
Phase 4 Terminated
NCT02812186 2020-04-08
Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery
Stony Brook University
Phase 4 Completed
NCT01136226 2018-10-24
Eligard
Chesapeake Urology Research Associates
Phase 4 Completed
NCT00859027 2018-05-01
Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer
UConn Health
Phase 4 Completed
NCT02441517 2018-04-19
A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment
Astellas Pharma Inc
Phase 4 Terminated
NCT00245518 2017-10-13
Effect of Soy on Cognition and Hot Flashes in Men With Prostate Cancer Undergoing Testosterone Suppression Therapy
Johns Hopkins University
Phase 4 Completed
NCT01296672 2017-10-06
3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer
The University of Texas Health Science Center at San Antonio
Phase 4 Completed
NCT00470834 2017-02-27
Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy
GlaxoSmithKline
Phase 4 Completed
NCT00363311 2017-01-18
Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men
GlaxoSmithKline
Phase 4 Completed
NCT01083199 2016-04-12
Global Performance Evaluation of the AMS CONTINUUMā¢ Device
American Medical Systems
Phase 4 Completed
NCT01161563 2013-09-06
Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration
Watson Pharmaceuticals
Phase 4 Completed
NCT00526331 2012-01-16
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy
M.D. Anderson Cancer Center
Phase 4 Completed
NCT00106392 2010-11-23
A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy
Astellas Pharma Inc
Phase 4 Completed